These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 24460192)
41. Lysophosphatidic Acid (LPA) Receptor 3-Mediated LPA Signal Transduction Pathways: A Possible Relationship with Early Development of Peri-Implantation Porcine Conceptus. Jeong W; Seo H; Sung Y; Ka H; Song G; Kim J Biol Reprod; 2016 May; 94(5):104. PubMed ID: 27030044 [TBL] [Abstract][Full Text] [Related]
42. Loss of lysophosphatidic acid receptor-3 enhances cell migration in rat lung tumor cells. Hayashi M; Okabe K; Yamawaki Y; Teranishi M; Honoki K; Mori T; Fukushima N; Tsujiuchi T Biochem Biophys Res Commun; 2011 Feb; 405(3):450-4. PubMed ID: 21255556 [TBL] [Abstract][Full Text] [Related]
43. Endocrine-disrupting potential of bisphenol A, bisphenol A dimethacrylate, 4-n-nonylphenol, and 4-n-octylphenol in vitro: new data and a brief review. Bonefeld-Jørgensen EC; Long M; Hofmeister MV; Vinggaard AM Environ Health Perspect; 2007 Dec; 115 Suppl 1(Suppl 1):69-76. PubMed ID: 18174953 [TBL] [Abstract][Full Text] [Related]
44. Anatomical location of LPA1 activation and LPA phospholipid precursors in rodent and human brain. González de San Román E; Manuel I; Giralt MT; Chun J; Estivill-Torrús G; Rodríguez de Fonseca F; Santín LJ; Ferrer I; Rodríguez-Puertas R J Neurochem; 2015 Aug; 134(3):471-85. PubMed ID: 25857358 [TBL] [Abstract][Full Text] [Related]
45. Lysophosphatidic acid receptor-3 increases tumorigenicity and aggressiveness of rat hepatoma RH7777 cells. Okabe K; Hayashi M; Kato K; Okumura M; Fukui R; Honoki K; Fukushima N; Tsujiuchi T Mol Carcinog; 2013 Apr; 52(4):247-54. PubMed ID: 22161812 [TBL] [Abstract][Full Text] [Related]
46. Constitutively active lysophosphatidic acid receptor-1 enhances the induction of matrix metalloproteinase-2. Kato K; Fukui R; Okabe K; Tanabe E; Kitayoshi M; Fukushima N; Tsujiuchi T Biochem Biophys Res Commun; 2012 Jan; 417(2):790-3. PubMed ID: 22197817 [TBL] [Abstract][Full Text] [Related]
47. Functional characterization of lysophosphatidic acid receptor 1 mutants identified in rat cancer tissues. Ishii S; Tsujiuchi T; Fukushima N Biochem Biophys Res Commun; 2017 May; 486(3):767-773. PubMed ID: 28342860 [TBL] [Abstract][Full Text] [Related]
48. Regulation of silicosis formation by lysophosphatidic acid and its receptors. Cong C; Mao L; Zhang Y; Zhao Z; Xu X; Zhao J Exp Lung Res; 2014 Sep; 40(7):317-26. PubMed ID: 24926730 [TBL] [Abstract][Full Text] [Related]
49. Autotaxin-LPA axis regulates hMSC migration by adherent junction disruption and cytoskeletal rearrangement via LPAR1/3-dependent PKC/GSK3β/β-catenin and PKC/Rho GTPase pathways. Ryu JM; Han HJ Stem Cells; 2015 Mar; 33(3):819-32. PubMed ID: 25376707 [TBL] [Abstract][Full Text] [Related]
51. Bisphenol A and nonylphenol have the potential to stimulate the migration of ovarian cancer cells by inducing epithelial-mesenchymal transition via an estrogen receptor dependent pathway. Kim YS; Hwang KA; Hyun SH; Nam KH; Lee CK; Choi KC Chem Res Toxicol; 2015 Apr; 28(4):662-71. PubMed ID: 25690688 [TBL] [Abstract][Full Text] [Related]
52. Unmasking of LPA1 receptor-mediated migration response to lysophosphatidic acid by interleukin-1β-induced attenuation of Rho signaling pathways in rat astrocytes. Sato K; Horiuchi Y; Jin Y; Malchinkhuu E; Komachi M; Kondo T; Okajima F J Neurochem; 2011 Apr; 117(1):164-74. PubMed ID: 21244430 [TBL] [Abstract][Full Text] [Related]
53. Lysophosphatidic acid stimulates prostaglandin E2 production in cultured stromal endometrial cells through LPA1 receptor. Woclawek-Potocka I; Kondraciuk K; Skarzynski DJ Exp Biol Med (Maywood); 2009 Aug; 234(8):986-93. PubMed ID: 19491366 [TBL] [Abstract][Full Text] [Related]
55. Lysophosphatidic acid receptors in cancer pathobiology. Tsujiuchi T; Araki M; Hirane M; Dong Y; Fukushima N Histol Histopathol; 2014 Mar; 29(3):313-21. PubMed ID: 24194373 [TBL] [Abstract][Full Text] [Related]
56. Involvement of lysophosphatidic acid (LPA) receptor-mediated signaling in breast cancer cell functions by long-term tamoxifen treatment under hypoxic and estrogen-deprived conditions. Takai M; Yamamoto M; Yashiro N; Tsujiuchi T Pathol Res Pract; 2024 Aug; 260():155385. PubMed ID: 38875757 [TBL] [Abstract][Full Text] [Related]
57. Lysophosphatidic acid and sphingosine 1-phosphate metabolic pathways and their receptors are differentially regulated during decidualization of human endometrial stromal cells. Brünnert D; Sztachelska M; Bornkessel F; Treder N; Wolczynski S; Goyal P; Zygmunt M Mol Hum Reprod; 2014 Oct; 20(10):1016-25. PubMed ID: 24994816 [TBL] [Abstract][Full Text] [Related]
58. Genistein suppressed epithelial-mesenchymal transition and migration efficacies of BG-1 ovarian cancer cells activated by estrogenic chemicals via estrogen receptor pathway and downregulation of TGF-β signaling pathway. Kim YS; Choi KC; Hwang KA Phytomedicine; 2015 Oct; 22(11):993-9. PubMed ID: 26407941 [TBL] [Abstract][Full Text] [Related]
59. Role of GPR120 in cell motile activity induced by 12-O-tetradecanoylphorbol-13-acetate in liver epithelial WB-F344 cells. Ishii S; Hirane M; Kitamura Y; Mori S; Fukushima N; Honoki K; Tsujiuchi T Mol Cell Biochem; 2015 Feb; 400(1-2):145-51. PubMed ID: 25380627 [TBL] [Abstract][Full Text] [Related]
60. LPA receptor-mediated signaling regulates cell motility and survival to anticancer drug of pancreatic cancer cells under glucose-deprived and hypoxic conditions. Takai M; Takauchi M; Kuribayashi M; Tsujiuchi T Biochem Biophys Res Commun; 2023 Jun; 661():21-27. PubMed ID: 37084489 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]